|
1
|
Random-clone strategy for genomic restriction mapping in yeast.
|
Proc Natl Acad Sci U S A
|
1986
|
6.44
|
|
2
|
Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
|
J Med Genet
|
2003
|
2.12
|
|
3
|
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
|
Am J Hum Genet
|
1997
|
1.96
|
|
4
|
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.
|
Am J Hum Genet
|
1996
|
1.70
|
|
5
|
Exon scanning for mutation of the NF2 gene in schwannomas.
|
Hum Mol Genet
|
1994
|
1.62
|
|
6
|
Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
|
Am J Hum Genet
|
2001
|
1.39
|
|
7
|
Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.
|
Radiology
|
2001
|
1.37
|
|
8
|
Frequency and distribution of NF2 mutations in schwannomas.
|
Genes Chromosomes Cancer
|
1996
|
1.34
|
|
9
|
Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
|
Am J Med Genet
|
1998
|
1.00
|
|
10
|
The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms.
|
Hum Mol Genet
|
1994
|
1.00
|
|
11
|
Cytosolic compartmentalization of hepatic alanine:glyoxylate aminotransferase in patients with aberrant peroxisomal biogenesis and its effect on oxalate metabolism.
|
J Inherit Metab Dis
|
1994
|
0.93
|
|
12
|
A clinical study of patients with multiple isolated neurofibromas.
|
J Med Genet
|
2001
|
0.92
|
|
13
|
Merlin: the neurofibromatosis 2 tumor suppressor.
|
Biochim Biophys Acta
|
1999
|
0.92
|
|
14
|
Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
|
Neurogenetics
|
1999
|
0.89
|
|
15
|
The parental origin of new mutations in neurofibromatosis 2.
|
Neurogenetics
|
2000
|
0.88
|
|
16
|
Neurofibromatosis 2: loss of merlin's protective spell.
|
Curr Opin Genet Dev
|
1996
|
0.87
|
|
17
|
Characterization and expression of the human A2a adenosine receptor gene.
|
J Neurochem
|
1996
|
0.85
|
|
18
|
Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
|
J Neuropathol Exp Neurol
|
1998
|
0.83
|
|
19
|
Monocular elevator paresis in neurofibromatosis type 2.
|
Neurology
|
2001
|
0.81
|
|
20
|
Genetic variation in the 3' untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression.
|
Somat Cell Mol Genet
|
1998
|
0.79
|
|
21
|
The effect of changes in hearing status on speech sound level and speech breathing: a study conducted with cochlear implant users and NF-2 patients.
|
J Acoust Soc Am
|
1998
|
0.78
|
|
22
|
Multiple meningiomas in brain and lung due to acquired mutation of the NF2 gene.
|
Neurology
|
2004
|
0.76
|
|
23
|
Molecular genetic screening for children at risk of neurofibromatosis 2.
|
Arch Otolaryngol Head Neck Surg
|
1995
|
0.76
|
|
24
|
Glioblastoma multiforme presenting as bilateral internal auditory canal tumors.
|
J Neurol
|
2006
|
0.75
|
|
25
|
Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia?
|
Acta Neuropathol
|
2000
|
0.75
|
|
26
|
Dominantly inherited, early-onset parkinsonism: neuropathology of a new form.
|
Neurology
|
1993
|
0.75
|